Clinical Trials on IV Injection

Total 60947 results

Pfizer

Completed

A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) Infection

Respiratory Syncytial Virus Infections

United Kingdom
Institute of Tropical Medicine, Belgium
KU Leuven; Université de Kisangani

Completed

Reservoir of Invasive Salmonellosis in Children, DRC

Salmonella Infections | Infection of Bloodstream

Congo, The Democratic Republic of the
Halmstad County Hospital

Completed

Review of Surgical Site Infection Registration Routine at Surgery Departments in Sweden and Validation of One of the Used Routines

Surgical Site Infections

Sweden
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Lenalidomide in Combination With Rituximab in Treating Participants With Stage III/IV Indolent Non-Hodgkin Lymphoma

Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Indolent Adult Non-Hodgkin... and other conditions

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Active, not recruiting

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Hormone Receptor Positive Breast Carcinoma | Metastatic Breast Carcinoma

United States, Puerto Rico, Ireland
Academic and Community Cancer Research United
National Cancer Institute (NCI)

Withdrawn

T-DM1 With or Without Abemaciclib for the Treatment of HER2-Positive Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | HER2 Positive Breast Carcinoma | Metastatic Breast Carcinoma

United States
Abderrahmane Mami Hospital

Recruiting

Epidemiological Features of Emergent Highly Resistant Bacteria in Tunisian Intensive Care Units (NOSOREA3)

Critical Illness | Cross Infection | Vancomycin-Resistant Enterococcal Infection | Carbapenem Resistant Bacterial Infection

Tunisia
Valenta Pharm JSC

Recruiting

Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections

Influenza, Human | Common Cold | Acute Respiratory Infection

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Influenza, Human | Common Cold | Acute Respiratory Infection

Russian Federation
Assiut University

Completed

Hepatitis D Virus Infection Among Hepatitis B Virus Surface Antigen Positive Individuals

HDV Infection | HBV Infection
Valenta Pharm JSC
Atlant Clinical Ltd.

Completed

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o.

Influenza, Human | Common Cold | Acute Respiratory Infection | Viral Infection

Russian Federation
National Cancer Institute (NCI)

Completed

RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditions

United States, Canada
Heinrich-Heine University, Duesseldorf
University of Osnabrueck

Completed

Fixation of Thoracic Epidurals Influencing Catheter-related Infections and Dislocation (TDPAFD)

Infection | Dislocation | Line Insertion Site | Line Colonisation

Germany
Rambam Health Care Campus

Unknown

The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis

Epstein-Barr Virus Infections | Cytomegalovirus | Herpesvirus Infection

Israel
National Cancer Institute (NCI)

Active, not recruiting

Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma

Grade 3a Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage III Grade 3 Follicular Lymphoma | Ann Arbor Stage...

United States
Hospital de Clinicas de Porto Alegre
The Isaac Foundation

Active, not recruiting

Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI

Mucopolysaccharidoses | Mucopolysaccharidosis VI | Morquio A Syndrome | Mucopolysaccharidosis IV A | MPS IV A | MPS VI | MPS - Mucopolysaccharidosis | Morquio Syndrome A | Morquio Syndrome

Brazil
Hospices Civils de Lyon

Completed

Severe Influenza Cohort (ANTIGRIPPE)

Influenza | Severe Respiratory Infection

France
Manuel Coelho da Rocha

Not yet recruiting

Tailored vs. Empirical Helicobacter Pylori Infection Treatment

Helicobacter Pylori Infection

Portugal
Shanghai Zhongshan Hospital

Recruiting

Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment

Helicobacter Pylori Infection

China
Second Affiliated Hospital of Xi'an Jiaotong University

Recruiting

Influencing Factors of Helicobacter Pylori Infection and Eradication Failure

Helicobacter Pylori Infection

China
University Hospital Freiburg

Recruiting

Pathogen-microbiome Interaction During Helicobacter Pylori Infection (PREDICTHP)

Helicobacter Pylori Infection

Germany
McGill University Health Centre/Research Institute...
Canadian Institutes of Health Research (CIHR)

Recruiting

Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection (TAPER-V)

Clostridium Difficile Infection

Canada
Hamdard University

Completed

Clinical Efficacy and Safety Assessment of Alsareen Capsule for the Management of H. Pylori Infection

H. Pylori Infection

Pakistan
Crestone, Inc
National Institute of Allergy and Infectious Diseases (NIAID)

Active, not recruiting

Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection

Clostridioides Difficile Infection

United States, Canada
Hellenic Institute for the Study of Sepsis

Completed

Addressing Personalized Needs in Clostridioides Difficile Infection (BEYOND)

Clostridioides Difficile Infection

Greece
TenNor Therapeutics (Suzhou) Limited

Completed

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TNP-2198 Capsules in Asymptomatic Participants With Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
Summit Therapeutics
Department of Health and Human Services

Terminated

Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects (Ri-CoDIFy 3)

Clostridioides Difficile Infection

United States
Centre Hospitalier Universitaire, Amiens

Completed

Nosocomial Outbreak of BHRe in an Intensive Care Unit During SARS-CoV-2 Pandemic (BHReICU)

Enterobacteriaceae Infections | Hospital-Acquired Infection

France
University of Virginia

Terminated

Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection

Clostridium Difficile Infection

United States
University Hospital, Basel, Switzerland
propatient foundation Basel

Completed

Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus (TARGET II)

Staphylococcus Aureus Infection

Switzerland
University of Leeds
GlaxoSmithKline; AstraZeneca; Sanofi Pasteur, a Sanofi Company; BioMérieux; Da Volterra and other collaborators

Completed

COMBACTE-CDI Understanding the Burden of C. Difficile Infection (COMBACTE-CDI)

Clostridium Difficile Infection

United Kingdom
Janssen Vaccines & Prevention B.V.
Bavarian Nordic

Terminated

Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix

Human Papillomavirus Infections

United States, Belgium
Federal State Budgetary Scientific Institution...
St. Petersburg State Pavlov Medical University; Moscow Clinical Scientific... and other collaborators

Completed

Helicobacter Pylori Infection Occurrence in Russia

Helicobacter Pylori Infection

Russian Federation
Antonio Mestrovic
University Hospital of Split; University of Split, School of Medicine

Completed

Comparison of Therapy in Treatment of Patients With Helicobacter Pylori Infection: Concomitant Versus Hybrid Therapy.

Helicobacter Pylori Infection

Croatia
University of Erlangen-Nürnberg Medical School

Completed

Immediate Detection of Helicobacter Infection With a New Electrochemical System.

H. Pylori Infection

Germany
Mayo Clinic
Rebiotix Inc.

Completed

Treatment of Recurrent Clostridium Difficile Infection With RBX7455

Clostridium Difficile Infection

United States
University of Split, School of Medicine

Completed

Quadruple vs Tailored Therapy in the Treatment of Helicobacter Pylori Infection

Helicobacter Pylori Infection

Croatia
Oslo University Hospital
University of Oslo

Terminated

IMT for Primary Clostridium Difficile Infection

Clostridium Difficile Infection

Norway
National Taiwan University Hospital

Completed

Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection

Helicobacter Pylori Infection

Taiwan
Hospital Universitario de Cabuenes
Merck Sharp & Dohme LLC; Hospital Universitario Central de Asturias; Instituto...

Unknown

PROSPECTIVE STUDY OF PREDISPOSING FACTORS OF REFRACTARY Clostridium Difficile INFECTION. INFLUENCE OF THE GUT MICROBIOMA

Clostridium Difficile Infection
Ayman Magd Eldin Mohammad Sadek

Completed

Comparison Between Quadruple Regimens for Helicobacter Pylori Infection in Egypt

Helicobacter Pylori Infection

Egypt
Kaohsiung Veterans General Hospital.
Kaohsiung Medical University Chung-Ho Memorial Hospital

Completed

Comparison of Two Rescue Therapies for Helicobacter Pylori Infection

Helicobacter Pylori Infection

Taiwan
Merck Sharp & Dohme LLC

Completed

A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002) (MODIFY II)

Clostridium Difficile Infection
National Taiwan University Hospital

Unknown

The Impact of Antibiotics MIC Value on the Efficacy of Treatment Regimens for Helicobacter Pylori Infection.

Helicobacter Pylori Infection

Taiwan
Kaohsiung Veterans General Hospital.

Completed

Concomitant, Sequential, and Standard Triple Therapy for H. Pylori Infection

Helicobacter Pylori Infection

Taiwan
Astellas Pharma S.A.S.

Completed

Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients (DAFNE)

Clostridium Difficile Infection

France
Dr. Luis Fernandez

Unknown

Study of the Usefulness of the Probiotic 'Lactobacillus Reuteri' in the Therapy of Quadruple Eradication of Helicobacter Pylori Infection in Usual Clinical Practice.

Helicobacter Pylori Infection

Spain
Hartford Hospital
Optimer Pharmaceuticals LLC

Completed

Study to Assess Inhibition of Spore Production in Patients With C. Difficile Infections: Fidaxomicin Versus Vancomycin

Clostridium Difficile Infection

United States
National Taiwan University Hospital

Unknown

Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection

Helicobacter Pylori Infection

Taiwan
Kaohsiung Veterans General Hospital.
Kaohsiung Medical University Chung-Ho Memorial Hospital

Completed

Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection (REHYTRI)

Helicobacter Pylori Infection

Taiwan

Clinical Trials on IV Injection

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations